Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy-Reference-Cited by-同舟云学术

Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy

Published:2021-12-28 Issue: Volume: Page:
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Gray Richard¹,Patel Smitaa²,Ives Natalie²,Rick Caroline²³,Woolley Rebecca²,Muzerengi Sharon⁴,Gray Alastair¹,Jenkinson Crispin¹,McIntosh Emma⁵,Wheatley Keith⁶,Williams Adrian⁴,Clarke C. E.²⁷,Young Keith⁸,Price Helen⁸,Price Jon⁸,Lambert Anne⁸,Reeve Robin⁸,Sewell Martin⁸,Broome Sally⁸,Williams Adrian⁸,Baker Mary⁸,Clarke Carl⁸,Fitzpatrick Ray⁸,Gray Alastair⁸,Greenhall Richard⁸,Jenkinson Crispin⁸,Mant David⁸,McIntosh Emma⁸,Sandercock Peter⁸,Baugent Colin⁸,Crome Peter⁸,Au Pui⁸,Boodell Thomas⁸,Cheed Versha Cheed⁸,Daniels Jane⁸,Dowling Francis⁸,Evans Lorraine⁸,Hawker Robert⁸,Kaur Surinder⁸,Rick Caroline⁸,Wheatley Keith⁸,Winkles Neil⁸,Hingley David⁸,Sturdy Lauren⁸,Wooley Rebecca⁸,Ottridge Ryan⁸,Peto Lisa⁸,Hilken Nicholas⁸,Counsell Carl⁸,Caie L.⁸,Caslake R.⁸,Coleman Richard⁸,Crowley P.⁸,Gerrie L.⁸,Gordon J.⁸,Harris C.⁸,Leslie V.⁸,MacLeod M.A.⁸,Taylor K.⁸,Worth Paul⁸,Barker R.A.⁸,Forsyth Duncan⁸,Halls M.⁸,Young J.⁸,Phillips Wendy⁸,Manford Mark⁸,Thangarajah N.⁸,Blake Debbie⁸,Prescott Richard⁸,Carr P.⁸,Cochrane L.⁸,Rose A.⁸,McLaren Andrew⁸,Drover M.⁸,Karunaratne P.⁸,Eady Amanda⁸,Wislocka-Kryjak Magdalena⁸,Ghaus N.⁸,Grueger A.⁸,Mallinson B.⁸,Wihl G.⁸,Ballantyne S.⁸,Hutchinson S.⁸,Lewthwaite Alistair⁸,Nicholl David⁸,Ritch A.⁸,Coyle S.⁸,Hornabrook R.⁸,Irfan H.⁸,Poxon S.⁸,Nath Uma⁸,Davison J.⁸,Dodds S.⁸,Robinson G.⁸,Gray C.⁸,Fletcher Peter⁸,Morrow P.⁸,Sliva M.⁸,Folkes E.⁸,Gilbert A.⁸,Hayes H.⁸,Burrows E.⁸,Donaldson Shona⁸,Lawrence J.⁸,Rhind G.⁸,Baxter G.⁸,Bell J.⁸,Gorman J.⁸,Guptha Sunku⁸,Noble C.⁸,Hindle John⁸,Jones S.⁸,Ohri P.⁸,Subashchandran R.⁸,Roberts E.⁸,Raw Jason⁸,Wadhwa U.⁸,Aspden L.⁸,Partington L.⁸,Vanek H.⁸,Whone Alan⁸,Barber Ronald⁸,Haywood Beverly⁸,Heywood Peter⁸,Lewis Helen⁸,O'Sullivan Karen⁸,Prout K.⁸,Whelan Liz⁸,Medcalf Pippa⁸,Sliva M⁸,Fuller G.⁸,Morrish P.⁸,Wales Emma⁸,Dalziel J.⁸,Overstall P.⁸,Bouifraden K.⁸,Evans Caroline⁸,Ward G.⁸,Matheson P.⁸,Lockington Timothy⁸,Graham A.⁸,Grimmer S.F.M.⁸,Sheehan L.J.⁸,Williams H.⁸,Hubbard Irene⁸,Walters R.⁸,Glasspool R.⁸,Critchley Peter⁸,Abbott R.⁸,Kendall B.⁸,Lawden M.⁸,Lo N.⁸,Rajaally Y.⁸,Simpson B.⁸,Martey J.⁸,Wray L. Goodwin⁸,Omar M.⁸,Sharma Avinash⁸,Gale A.⁸,Phirii D.⁸,Sekaran L.⁸,Wijayasiri S.⁸,Silverdale Monty⁸,Walker D.⁸,Fleary H.⁸,Monaghan A.⁸,Senthil Viswanathan⁸,Reynolds S.⁸,Chong M. S.⁸,Diem D.⁸,Kundu B.⁸,Arnold D.⁸,Quinn N.⁸,Benamer H.⁸,Billings J.⁸,Corston R.⁸,D'Costa D.⁸,Green M.⁸,Shuri J.⁸,Noble J.M.⁸,Cassidy T.⁸,Gani A.⁸,Lawson R.⁸,Nirubin Alagaratnam⁸,Cochius J.⁸,Dick D.⁸,Lee M.⁸,Payne B.⁸,Roche M.⁸,Sabanathan K.⁸,Shields S.⁸,Hipperson M.⁸,Reading F.⁸,Saunders Julia⁸,Harper G.⁸,Honan W.⁸,Gill L.⁸,Stanley J.⁸,Vernon Nathan⁸,Skinner A.⁸,McCann P.⁸,Walker Richard⁸,Edmonds P.⁸,O'Hanlon S.⁸,Wood Brian⁸,Hand A.⁸,Robinson L.⁸,Liddle Jane⁸,Bolam D.⁸,Raha Sandip⁸,Ebebezer Louise⁸,Thompson S.⁸,Pall H.⁸,Praamstra P.⁸,Crouch Rose⁸,Healy Karen⁸,Johnson M.⁸,Jenkinson Michael⁸,Abdel-Hafiz A.⁸,Al-Modaris F.⁸,Dutta S.⁸,Mallik T.⁸,Mondal B.⁸,Roberts J.⁸,Sinha S.⁸,Amar Khaled⁸,Atkins S.⁸,Devadason G.⁸,Martin A.⁸,Cox C.⁸,Malone Timothy⁸,Fenwick G.⁸,Gormley K.⁸,Gutowski N.⁸,Harris S.⁸,Harrower T.⁸,Hemsley A.⁸,James M.⁸,Jeffreys M.O.⁸,Pearce Vaughn⁸,Sheridan Raymond⁸,Sword J.⁸,Zeman A.⁸,Soper C.⁸,Vassallo Joseph⁸,Bennett J.⁸,Lyell Veronica⁸,Robertson D.⁸,Howcroft D.⁸,Mugweni K.⁸,Stephens A.⁸,Whelan E.⁸,Wright A.⁸,Chamberlain J.⁸,Padiachy Diran⁸,Marigold J.⁸,Lee J.⁸,Roberts Helen⁸,Adams J.⁸,Dulay J.⁸,Evans S.⁸,Frankel J.⁸,Gove R.⁸,Turner G.⁸,Mallik N.⁸,McElwaine Tracey⁸,Morgan S.⁸,Phipps H.⁸,Pressly V.⁸,Queen V.⁸,Tan R.⁸,Grossett Donald⁸,Macphee G.⁸,Vennard Carol⁸,Rektorova Irena⁸,Dhakam Zahid⁸,Carey G.⁸,Castledon B.⁸,Sunderland C.⁸,Kalcantera E.⁸,Long C.⁸,Mandal B.⁸,Martin V.⁸,Nari R.⁸,Nicholas V.⁸,Moffitt Virginia⁸,Hammans S.⁸,Rice-Oxley M.⁸,Webb Julie⁸,Franks S.⁸,Cooper Simon⁸,Hussain M.⁸,Solanki T.⁸,Darch W.⁸,Homan J.⁸,Sharratt D.⁸,Griggs Gareth⁸,Kendall G.⁸,Ford A.⁸,Stocker K.⁸,Strens Lucy⁸,Grubneac A.⁸,Ponsford J.⁸,Teare L.⁸,Moore Austen Peter⁸,O'Brien I.⁸,Watling D.⁸,Wyatt L.⁸,Rizvi Syed⁸,Walker Elaine⁸,Berry G.⁸,Russell N.⁸,Rashed Khalid⁸,Baker K.⁸,Qadiri M.R.⁸,Buckley C.⁸,Bulley S.⁸,Gibbons D.⁸,Goodland R.⁸,Heywood P.⁸,Jones L.⁸,Martin L.⁸,Rowland-Axe R.⁸,Stone A.⁸,Whittuck M.R.⁸,

Affiliation:

1. Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom

2. Birmingham Clinical Trials Unit, Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom

3. Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, United Kingdom

4. Department of Neurology, University Hospital, Birmingham, United Kingdom

5. Health Economics and Health Technology Assessment, University of Glasgow, Glasgow, United Kingdom

6. Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences. University of Birmingham, Birmingham, UK

7. Department of Neurology, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, United Kingdom

8. for the PD MED Collaborative Group

Publisher

American Medical Association (AMA)

Subject

Neurology (clinical)

Link

https://jamanetwork.com/journals/jamaneurology/articlepdf/2787405/jamaneurology_gray_2021_oi_210082_1640103773.73219.pdf

Reference26 articles.

1. Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson’s disease (PD MED): a large, open-label, pragmatic randomised trial.;Gray;Lancet,2014

2. Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson s disease patients with motor complications.;Stowe;Cochrane Database Syst Rev,2010

3. Meta-analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson’s disease.;Stowe;Mov Disord,2011

4. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease.;Gibb;J Neurol Neurosurg Psychiatry,1988

5. Large-scale randomized evidence: large, simple trials and overviews of trials.;Peto;J Clin Epidemiol,1995

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose‐Driven Approach;Movement Disorders;2024-01-20

2. Impact of Istradefylline on Levodopa Dose Escalation in Parkinson’s Disease: ISTRA ADJUST PD Study, a Multicenter, Open-Label, Randomized, Parallel-Group Controlled Study;Neurology and Therapy;2024-01-16

3. Medical, surgical, and physical treatments for Parkinson's disease;The Lancet;2024-01

4. Type-B monoamine oxidase inhibitors in neurological diseases;Neural Regeneration Research;2024-01

5. Understanding the Therapeutic Approaches for Neuroprotection;Current Pharmaceutical Design;2023-11